2084 Distinguishing between Fabry's disease and hypertrophic cardiomyopathy with early enhancement

2084 Distinguishing between Fabry's disease and hypertrophic cardiomyopathy with early enhancement

Bibliographic Details
Main Authors:	Friedrich Matthias G, Strohm Oliver, Cocker Myra S
Format:	Article
Language:	English
Published:	Elsevier 2008-10-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Mosaic Fabry Disease in a Male Presenting as Hypertrophic Cardiomyopathy
by: Maria Xu, et al.
Published: (2020-12-01)

2084
by: Jane Otado, et al.
Published: (2017-09-01)

Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy
by: Kamil Stankowski, et al.
Published: (2023-11-01)

Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
by: Andrea Frustaci, et al.
Published: (2023-12-01)

Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic
by: David Zemánek, et al.
Published: (2022-12-01)

Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
by: Ravi Vijapurapu, et al.
Published: (2022-01-01)

Evaluation of papillary myocardial infarction: incremental value of a short time inversion vs standard late enhancement imaging
by: Friedrich Matthias, et al.
Published: (2011-02-01)

GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
by: Ândrea Virgínia Chaves-Markman, et al.

Description of a New GLA Gene Variant in a Patient with Hypertrophic Cardiomyopathy. Is it Fabry Disease?
by: Marcelo Imbroinise Bittencourt

The Prevalence of Fabry Disease Among Turkish Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Insights from a Screening Study
by: Hasan Ali Barman, et al.
Published: (2019-11-01)

Myocardial deformation imaging and rare cardiomyopathies with hypertrophic phenotype: a review focused on Fabry disease, Friedreich ataxia and amyloidosis
by: Bahaa Fadel, et al.
Published: (2013-06-01)

John Lennox: 2084: Artificial Intelligence and the Future of Humanity
by: Philipp Koebe
Published: (2024-01-01)

Hypertrophic Cardiomyopathy
by: Asra K. Butt, et al.
Published: (2023-03-01)

Hypertrophic cardiomyopathy
by: Sarita Gore, et al.
Published: (2022-01-01)

Hypertrophic Cardiomyopathy
by: Polakit Teekakirikul, MD, et al.
Published: (2021-09-01)

Hypertrophic cardiomyopathy
by: Murillo de Oliveira Antunes, et al.
Published: (2020-04-01)

Immune‐Mediated Myocarditis in Fabry Disease Cardiomyopathy
by: Andrea Frustaci, et al.
Published: (2018-09-01)

The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology
by: K. Savostyanov, et al.
Published: (2022-05-01)

HYPERTROPHIC CARDIOMYOPATHY IN MULTIMORBIDITY
by: A. I. Lakhonina, et al.
Published: (2016-06-01)

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
by: A. G. Osiev, et al.
Published: (2016-02-01)

Management of Hypertrophic Cardiomyopathy
by: Alan D. Enriquez, et al.
Published: (2014-04-01)

Myocardial fibrosis is a prevalent finding in elite high-endurance athletes
by: Friedrich Matthias G, et al.
Published: (2009-01-01)

Sub-clinical systolic dysfunction with persistent myocardial edema and inflammation in elite high-endurance athletes with common colds: a cardiovascular magnetic resonance study
by: Friedrich Matthias G, et al.
Published: (2009-01-01)

On Constructions of One-Lee Weight Codes Over Z₄
by: Zongbing Lin, et al.
Published: (2021-01-01)

Copper chelation in patients with hypertrophic cardiomyopathy
by: Matthias Schmitt, et al.
Published: (2022-02-01)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
by: Megan J. Puckelwartz, et al.
Published: (2021-04-01)

Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy
by: Konstantinos C. Siontis, et al.
Published: (2019-11-01)

Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
by: Pal, N
Published: (2015)

Danon’s disease as a cause of hypertrophic cardiomyopathy
by: I. V. Leontyeva, et al.
Published: (2016-03-01)

The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy
by: Deniz Alis, et al.
Published: (2021-04-01)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
by: Kramer, CM, et al.
Published: (2018)

The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease
by: Shengliang Liu, et al.
Published: (2022-05-01)

Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model
by: Sabrina Stücker, et al.
Published: (2017-08-01)

Multimodality Imaging of Fabry Disease Cardiomyopathy Complicated With Coronary Vasospasm
by: Tomohiro Tahara, MD, et al.
Published: (2024-04-01)

Allele-specific dysregulation of lipid and energy metabolism in early-stage hypertrophic cardiomyopathy
by: Arpana Vaniya, et al.
Published: (2024-06-01)

Sudden death in hypertrophic cardiomyopathy.
by: Watkins, H
Published: (2000)

Myocardial dysfunction in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2001)

The genetic architecture of hypertrophic cardiomyopathy
by: Harper, AR
Published: (2020)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
by: Francesco Pelliccia, et al.
Published: (2022-11-01)

Syncope in children with hypertrophic cardiomyopathy
by: I. V. Leontyeva, et al.
Published: (2016-03-01)